HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China. These subsidiaries are primarily dedicated to localized market expansion, institutional partnerships, and frontline sales execution for GV’s regenerative medicine, cellula ...

Hinge Health, Inc. (NYSE:HNGE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares Hinge Health, Inc. (NYSE:HNGE) secures third place on our list of innovative healthcare stocks. TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares. The analyst pointed out that the retreat offers an interesting chance for investo ...

Core Viewpoint - Waystar Holding Corp. has demonstrated significant financial improvement, achieving profitability and a strong growth outlook, which has positively influenced its stock performance [1][4]. Financial Performance - Waystar reported a net income of $112 million for the last year, a turnaround from a net loss of $19 million in 2024 [1]. - The company's revenues exceeded $1 billion, reaching $1.099 billion, reflecting a 16% increase from $943.5 million year-on-year [2]. - In the fourth quarter, Waystar's net income was $19.99 million, up 4.8% from $19.08 million in the same quarter the previous year, with revenues of $303.5 million, a 24% increase from $244 million year-on-year [4]. Future Guidance - For 2026, Waystar aims for a non-GAAP net income increase of 20.6% to 27%, targeting $317 million to $335 million compared to $262.9 million in 2025 [5]. - Revenue projections for 2026 are set between $1.274 billion and $1.294 billion, indicating an implied growth of 16% to 17.7% year-on-year [5]. - Adjusted EBITDA is expected to be between $530 million and $540 million, representing a 14.7% to 16.8% increase from $462.1 million in the same comparable period [5]. Strategic Positioning - The company is positioning itself as a leader in healthcare's AI transformation, focusing on enhancing the autonomous revenue cycle through proprietary data and domain expertise [6].

Core Insights - Waystar Holding Corp. (NASDAQ:WAY) is recognized as one of the 15 innovative healthcare stocks to buy according to analysts [1] Group 1: Analyst Ratings and Price Targets - Mizuho has lowered its price target for Waystar to $42 from $50 while maintaining an Outperform rating, reflecting a reassessment of competitive risks in the healthcare technology sector [2] - Leerink initiated coverage of Waystar with an Outperform rating and a price target of $43, citing the company's broad market reach and growth potential [3] Group 2: Company Developments and Innovations - Waystar announced the resignation of Chief Business Officer Eric Sinclair III, effective March 2, 2026, with no disagreements involved and a 2025 annual bonus to be received [4] - The company has integrated agentic intelligence into its healthcare payment platform and upgraded its AltitudeAI system, which has prevented $15.5 billion in claim denials in under a year, showcasing its operational enhancements [4] Group 3: Company Overview - Waystar is a U.S. healthcare technology company that modernizes healthcare payments through a cloud-native, AI-powered revenue cycle management platform, improving claim accuracy and patient payment experiences [5]

WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Heal ...

Last year, Chris Heckler was coming to the end of a five-year non-compete after selling his last company, a healthcare startup. “I was sitting on the sidelines doing angel investing, and I realized I was too young to retire,” he told TechCrunch. “I wanted to get back into it.” At the same time, Joseph Akintolayo had just sold his fintech company. He, too, had a non-compete, but was noodling on ideas for a company. He knew Heckler, as Akintolayo had once served as an advisor on one of his projects. In ...

Core Insights - Waystar has been recognized as an Inc. Best in Business honoree in the Best AI Implementation category, highlighting its excellence in AI execution and significant business impact [1][5] Group 1: AI Implementation and Impact - The rapid market adoption of Waystar AltitudeAI has led to clients preventing $15.5 billion in denials, achieving 95% time savings in denial prevention workflows, and increasing denial overturn rates by double digits [2] - Waystar's AI advantage is based on a mission-critical system of record that integrates financial, clinical, and administrative intelligence, allowing AI agents to resolve payment issues effectively [3] Group 2: Client Success and Growth - Advocate Health, a large nonprofit health system, utilizes Waystar's software to enhance administrative workflows and support rapid growth, emphasizing the positive impact on patient service [4] - Waystar serves over 30,000 clients, representing over 1 million distinct providers, and processes over 7.5 billion healthcare payment transactions annually, amounting to over $2.4 trillion in gross claims [7]

Judy Faulkner founded medical-record software provider Epic Systems in a Wisconsin basement in 1979. Now, the computer programmer is CEO of the company that supports medical records of over 250 million patients. Faulkner is recognized on the #Forbes250 list, featuring America’s greatest living innovators.Get the full list: https://t.co/kszvRsR2NBPhoto: Guerin Blask for Forbes ...

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company’s fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https: ...

HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference CallFeb 12, 2026 9:25 AM Eastern Standard Time# HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference CallShare---NASHVILLE, Tenn.--([BUSINESS WIRE])--HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, announced today that it will host a conference call and webcast to discuss its fourth quarter & full-year 2025 financial results on Tuesday, February 24, 2026. ...